These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 1664827

  • 21. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
    Wexler HM, Molitoris E, Molitoris D, Finegold SM.
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617
    [Abstract] [Full Text] [Related]

  • 22. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
    King A, Bethune L, Phillips I.
    J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
    [Abstract] [Full Text] [Related]

  • 23. Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.
    Whiting JL, Cheng N, Chow AW.
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1379-82. PubMed ID: 3674848
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Comparative in-vitro and in-vivo activity of AM-1155 against anaerobic bacteria.
    Kato N, Kato H, Tanaka-Bandoh K, Watanabe K, Ueno K.
    J Antimicrob Chemother; 1997 Nov; 40(5):631-7. PubMed ID: 9421310
    [Abstract] [Full Text] [Related]

  • 26. Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes.
    Spangler SK, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():23-7. PubMed ID: 9222066
    [Abstract] [Full Text] [Related]

  • 27. [In vitro activity of a new fluoroquinolone, marbofloxacin (RO 09-1168) against strictly anaerobic bacteria and some bacteria from human fecal flora].
    Dubreuil L, Houcke I, Leroy I.
    Pathol Biol (Paris); 1996 May; 44(5):333-6. PubMed ID: 8758470
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of in vitro activities of DU-6859a and other fluoroquinolones against Japanese isolates of anaerobic bacteria.
    Kato N, Kato H, Tanaka-Bando K, Watanabe K, Ueno K.
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S31-5. PubMed ID: 8953104
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP, Pottumarthy S, Morris AJ.
    N Z Med J; 1999 Nov 12; 112(1099):424-6. PubMed ID: 10678225
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
    Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.
    Drugs Exp Clin Res; 1992 Nov 12; 18(8):311-7. PubMed ID: 1338041
    [Abstract] [Full Text] [Related]

  • 39. The in-vitro activity of temafloxacin, against gram-positive bacteria.
    Mandell LA, Lawrence T, Rotstein C, Gorzynski EA, Beam TR, Amsterdam D.
    J Antimicrob Chemother; 1991 Dec 12; 28 Suppl C():15-24. PubMed ID: 1664826
    [Abstract] [Full Text] [Related]

  • 40. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
    Barry AL, Fuchs PC.
    J Antimicrob Chemother; 1991 Nov 12; 28(5):695-9. PubMed ID: 1663929
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.